8 recruiting, 7 completed, 5 active not recruiting, 5 terminated. 13 Phase 2, 9 Phase 1, 5 Not applicable, 4 Phase 3.
Follow Bone Marrow Aspirate: new trials by email Literature Review of Bone Marrow Aspirate trials Research Report on Bone Marrow Aspirate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Varying Bone Marrow-Derived Mesenchymal Stem Cells Concentrations' Impact on Rotator Cuff Repair Outcomes Rotator cuff repair augmented with whole bone marrow, Rotator cuff repair augmented with concentrated bone marrow - Rotator Cuff Tears | Not applicable | Withdrawn | Johns Hopkins University | 2025-02-01 | 2024-11-29 | |
| A Reduced-Intensity Conditioning Regimen (Cyclophosphamide, Pentostatin, Anti-thymocyte Globulin) Followed by Haploidentical Hematopoietic Stem Cell Transplant for the Treatment of Patients With Refractory or Recurrent Severe Aplastic Anemia Anti-Thymocyte Globulin, Biospecimen Collection, Bone Marrow Aspirate - Recurrent Severe Aplastic Anemia, Refractory Severe Aplastic Anemia | Phase 1 | Recruiting | City of Hope Medical Center | 6 | 2024-11-15 | 2026-01-05 |
| Magrolimab in Combination with Azacitidine After Allogeneic HCTin Treating Patients with High-Risk AML or MDS Allogeneic Hematopoietic Stem Cell Transplantation, Azacitidine, Biospecimen Collection - Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 1 | Withdrawn | City of Hope Medical Center | 2024-10-09 | 2024-09-19 | |
| Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases Biospecimen Collection, Bone Marrow Aspirate, Cyclophosphamide - Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia | Phase 2 | Recruiting | Fred Hutchinson Cancer Center | 54 | 2024-07-23 | 2026-07-22 |
| Treatment of Knee Osteoarthritis With Bone Marrow Aspirate Matrix: Prospective, Randomized Trial Bone marrow aspirate matrix, Bone marrow aspirate, Hyaluronic acid - Knee Osteoarthritis | Phase 3 | Not yet recruiting | Instituto Nacional de Traumatologia e Ortopedia | 90 | 2024-03-01 | 2024-02-02 |
| Alternate Doses and Dosing Schedules of Belantamab Mafodotin for Treatment of Triple-Class Refractory Multiple Myeloma Belantamab Mafodotin, Biospecimen Collection, Bone Marrow Aspirate - Recurrent Multiple Myeloma, Refractory Multiple Myeloma | Phase 2 | Recruiting | Mayo Clinic | 62 | 2024-01-04 | 2026-07-14 |
| Allogeneic Hematopoietic Stem Cell Transplantation With Briquilimab-Based Conditioning in Participants With GATA2 Deficiency Mycophenolate Mofetil, Tacrolimus, Post-Transplant Cyclophosphamide - GATA2, Immunodeficiency | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 13 | 2023-11-29 | 2026-08-11 |
| Eltanexor (KPT-8602) With Inqovi (Decitabine-Cedazuridine) in High-Risk Myelodysplastic Syndromes KPT-8602, Inqovi, Bone marrow aspirate - Myelodysplastic Syndromes | Phase 1 / Phase 2 | Terminated | National Cancer Institute (NCI) | 3 | 2023-11-14 | 2025-12-02 |
| FoxO3a and PU.1 in Acute Lymphoblastic Leukemia complete blood count - Acute Lymphoblastic Leukemia | Unknown | Assiut University | 53 | 2023-08-01 | 2023-02-08 | |
| Precision Medicine for Stem Cell Transplantation Blood sample collection, Bone marrow aspirate - Haematopoietic Stem Cell Transplantation | Recruiting | University of Manchester | 300 | 2023-06-06 | 2025-04-03 | |
| Mesenchymal Stem Cell Therapy for Knee Osteoarthritis Bone Marrow Derived MSCs, Corticosteroid, Bone Marrow Aspirate - Osteoarthritis, Knee | Phase 1 / Phase 2 | Unknown | Next Generation Regenerative Medicine LLC | 120 | 2022-08-01 | 2022-03-21 |
| Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes Dilanubicel, Cyclophosphamide, Fludarabine - Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia | Phase 2 | Active not recruiting | Fred Hutchinson Cancer Center | 31 | 2022-05-10 | 2026-07-10 |
| Testing the Addition of Ixazomib/Placebo to Lenalidomide in Patients With Evidence of Residual Multiple Myeloma, OPTIMUM Trial Biospecimen Collection, Bone Marrow Aspirate, Bone Marrow Biopsy - Multiple Myeloma | Phase 3 | Completed | National Cancer Institute (NCI) | 1 | 2022-02-16 | 2025-05-23 |
| CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma Biospecimen Collection, Bone Marrow Aspirate, Bone Marrow Biopsy - Diffuse Midline Glioma, H3 K27-Altered, Metastatic Malignant Neoplasm in the Central Nervous System | Phase 1 / Phase 2 | Recruiting | Children's Oncology Group | 63 | 2022-01-28 | 2026-09-11 |
| Immune Profile of Acute Myeloid Leukemia Patients Receiving Azacitidine Plus Venetoclax Induction Chemotherapy Biospecimen Collection, Bone Marrow Aspirate, Electronic Health Record Review - Acute Myeloid Leukemia | Recruiting | Mayo Clinic | 80 | 2021-04-22 | 2026-04-01 | |
| Pemigatinib After Chemotherapy for the Treatment of Newly Diagnosed Acute Myeloid Leukemia Biospecimen Collection, Bone Marrow Aspirate, Bone Marrow Biopsy - Acute Myeloid Leukemia | Phase 1 | Recruiting | OHSU Knight Cancer Institute | 32 | 2021-01-14 | 2026-07-14 |
| Investigating Marrow Infiltrating Lymphocytes in Renal Cell Carcinoma Bone Marrow Aspirate - Renal Cell Carcinoma, Urothelial Carcinoma | Not applicable | Terminated | University of Oklahoma | 6 | 2020-07-22 | 2023-12-13 |
| AML/MDS Drug Sensitization by in Vivo Chemotherapy Administration Peripheral blood draw, Bone marrow aspirate, Buccal swab - Acute Myeloid Leukemia, Myelodysplastic Syndromes | Active not recruiting | Washington University School of Medicine | 80 | 2020-01-29 | 2026-03-02 | |
| MCS110 Combined With Neoadjuvant Doxorubicin, Cyclophosphamide, and Weekly Paclitaxel in Patients With Hormone-Receptor Positive and HER2- Breast Cancer MCS110, Doxorubicin, Cyclophosphamide - Breast Cancer, Cancer of Breast | Phase 1 | Withdrawn | Washington University School of Medicine | 2018-09-30 | 2018-08-16 | |
| Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone Biospecimen Collection, Bone Marrow Aspirate, Bone Marrow Biopsy - Endometrial Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 288 | 2018-09-27 | 2026-10-22 |
Showing 20 of 33. Sign in to see all of them.
Leukemia, Myeloid, Acute (7) · Myelodysplastic Syndromes (7) · Osteoarthritis (3) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (3) · Leukemia, Biphenotypic, Acute (2) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (2) · Lymphoma (2) · Lymphoma, Non-Hodgkin (2) · Multiple Myeloma (2) · Myeloproliferative Disorders (2) · Osteoarthritis, Knee (2) · Anemia, Aplastic (1) · Anemia, Refractory, with Excess of Blasts (1) · Arthritis (1) · Blastic Plasmacytoid Dendritic Cell Neoplasm (1)
National Cancer Institute (NCI) (5) · Washington University School of Medicine (5) · City of Hope Medical Center (2) · Fred Hutchinson Cancer Center (2) · Mayo Clinic (2) · Royal Marsden NHS Foundation Trust (2) · Assiut University (1) · Children's Oncology Group (1) · Dr. E.Badiavas (1) · ECOG-ACRIN Cancer Research Group (1) · Institut Paoli-Calmettes (1) · Instituto Nacional de Traumatologia e Ortopedia (1) · Johns Hopkins University (1) · Next Generation Regenerative Medicine LLC (1) · Novartis Pharmaceuticals (1)
United States (21) · United Kingdom (3) · Canada (2) · Australia (1) · Belgium (1) · Brazil (1) · France (1) · Puerto Rico (1) · Saudi Arabia (1) · Spain (1)
David Taussig (2) · Meagan Jacoby, M.D. (2) · Abhishek Tripathi, MD (1) · Ann Dahlberg (1) · Christopher J Melani, M.D. (1) · Danielle E Pregent-Arnold, M.D. (1) · David S Ziegler (1) · Elie Traer, MD PhD (1) · Evangelos V Badiavas, MD, PhD (1) · Filippo Milano (1) · Geoffrey Uy, M.D. (1) · Helen J Mackay (1) · James G Unnerstall (1) · John M Centanni, MS (1) · Leonel Hernandez-Aya, M.D. (1)
PMID 23828551, PMID 25408859, PMID 33288485, PMID 34050021, PMID 36485104, PMID 37011643, PMID 38127487, PMID 38462984, PMID 38954834, PMID 40474797, PMID 41180818
P30CA033572 (2), U10CA180820 (2), P30CA015704 (1), P50HL110787 (1), R01AG027874 (1), U10CA180868 (1), UM1CA228823 (1)